supercritical fluid technology Adjust Font Size:
Decrease Increase  Micell's supercritical fluid technology (SCF)
provides several unique advantages in the modification and
coating of biomedical surfaces with advanced polymers and drugs.
Compared to current solvent-based coating systems, Micell's
technology for creating drug-eluting coatings is:  Dry - Meaning
that polymers, drugs and medical devices are not exposed to
conventional liquid solvents.  Cool - Our processes function at
moderate temperatures to preserve the structure and morphology
of therapeutic agents.  Flexible - By combining electrostatic
attraction with supercritical fluids, Micell can create surface
modifications for a broad range of medical devices using a
variety of polymers and drugs.  The supercritical fluid process
allows the use of therapeutic agents that may be sensitive to
elevated temperatures or traditional solvent processes. Most
existing coating processes for medical devices involve an
organic solvent that may alter the chemistry